Total Payments
$1,051
2024 Payments
$367.49
Companies
12
Transactions
64
Medicare Patients
482
Medicare Billing
$114,092
Payment Breakdown by Category
Food & Beverage$1,004 (95.5%)
Education$46.91 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,004 | 63 | 95.5% |
| Education | $46.91 | 1 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $318.60 | 14 | $0 (2024) |
| Allergan Inc. | $266.10 | 25 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $100.51 | 5 | $0 (2024) |
| ITI, Inc. | $86.53 | 3 | $0 (2023) |
| Alkermes, Inc. | $84.56 | 4 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $81.02 | 4 | $0 (2024) |
| Axsome Therapeutics, Inc. | $30.07 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $20.04 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $19.96 | 1 | $0 (2019) |
| Indivior Inc. | $15.89 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.49 | 15 | ABBVIE INC. ($160.32) |
| 2023 | $250.30 | 13 | ABBVIE INC. ($136.39) |
| 2021 | $68.80 | 2 | ITI, Inc. ($46.91) |
| 2019 | $34.74 | 2 | Janssen Pharmaceuticals, Inc ($19.96) |
| 2018 | $145.95 | 13 | Allergan Inc. ($110.10) |
| 2017 | $183.66 | 19 | Allergan Inc. ($156.00) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: CNS | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Neuropsychiatry | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Neurology | ||||||
| 07/09/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: CNS | ||||||
| 06/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Neuropsychiatry | ||||||
| 04/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Central Nervous System | ||||||
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: BH | ||||||
| 11/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Neurology | ||||||
| 10/24/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 103 | 339 | $47,403 | $22,412 |
| 2022 | 3 | 117 | 402 | $57,889 | $26,797 |
| 2021 | 3 | 124 | 481 | $70,555 | $34,974 |
| 2020 | 3 | 138 | 495 | $69,643 | $29,910 |
Total Patients
482
Total Services
1,717
Medicare Billing
$114,092
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 269 | $26,900 | $16,653 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 58 | $13,853 | $4,453 | 32.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $6,650 | $1,305 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 306 | $29,328 | $19,229 | 65.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 80 | $19,798 | $5,758 | 29.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $8,763 | $1,810 | 20.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 353 | $33,535 | $23,123 | 69.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 114 | $28,536 | $10,072 | 35.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 14 | $8,484 | $1,778 | 21.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 88 | 386 | $36,670 | $21,062 | 57.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 91 | $22,777 | $6,879 | 30.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 18 | 18 | $10,196 | $1,970 | 19.3% |
About Dr. Gregg Etter, MD
Dr. Gregg Etter, MD is a Addiction (Substance Use Disorder) healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962409649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregg Etter, MD has received a total of $1,051 in payments from pharmaceutical and medical device companies, with $367.49 received in 2024. These payments were reported across 64 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,004).
As a Medicare-enrolled provider, Etter has provided services to 482 Medicare beneficiaries, totaling 1,717 services with total Medicare billing of $114,092. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction (Substance Use Disorder)
- Other Specialties Psychiatry
- Location Warwick, RI
- Active Since 07/07/2005
- Last Updated 01/14/2010
- Taxonomy Code 103TA0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962409649
Products in Payments
- VRAYLAR (Drug) $584.70
- INGREZZA (Drug) $100.51
- CAPLYTA (Drug) $86.53
- UZEDY (Drug) $59.34
- Auvelity (Drug) $30.07
- ARISTADA (Drug) $25.07
- VIVITROL (Drug) $21.83
- Austedo XR (Drug) $21.68
- Aristada 441 mg (Drug) $20.92
- COBENFY (Drug) $20.04
- INVEGA SUSTENNA (Drug) $19.96
- Vivitrol (Drug) $16.74
- PERSERIS (Drug) $15.89
- LATUDA (Drug) $14.32
- TRINTELLIX (Drug) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction (Substance Use Disorder) Doctors in Warwick
Carole Seifert, Ma, Lcdp, MA, LCDP
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Donald Labonte, M.a., M.s.w, M.A., M.S.W
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Lee Dalphonse, Lmhc, Lcds, Ccmhc, LMHC, LCDS, CCMHC
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Dennis Joyce, Lcdp, LCDP
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Deborah Rezendes, M.ed, Lcdp, M.ED, LCDP
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Sheelah Mailoi, Bs, Lcdp11, Rcs,Ccjp, BS, LCDP11, RCS,CCJP
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)